Pediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT ID: NCT01198717
Last Updated: 2021-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2010-09-28
2016-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
NCT06281327
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
NCT01895777
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shire
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Study Director
Role: STUDY_DIRECTOR
Takeda
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Paediatric Clinic University Hospital Olomouc
Olomouc, , Czechia
Clinic of Paediatric haematology and oncology University Hospital Motol
Prague, , Czechia
Paediatric Oncology Unit, Hopital Cote De Nacre
Caen, , France
Practicen Hospitalier , Institute d'Hematologie et Oncologie Pediatrique
Lyon, , France
Centre Hospitalier Lyon Sud - service Hématologie
Pierre-Bénite, , France
Hopitaux de Brabois
Vandœuvre-lès-Nancy, , France
Klinikum Chemnitz GmbH, Klinik für Kinder-und Jugendmedizin
Chemnitz, , Germany
Zentrum für Kinder- und Jugendmedizin Klinik II / III
Frankfurt, , Germany
"Agia Sophia" Children's Hospital
Athens, , Greece
Dipartimento di Biomedicina dell'Eta Evolutiva. University of Bari
Bari, , Italy
Servico de Oncoematologia Peditrica
Cagliari, , Italy
UO Oncoematologia AOU Meyer
Florence, , Italy
Pediatric Hamatology Unit. Department of Hematology and Oncology. G Gaslini Children's hospital. Largo
Genova, , Italy
Chairmen of Pediatric Hamatooncology Outpatient Clinic. Hospital San Gerardo
Monza, , Italy
Department of Oncology, Pausilipon Hospital, AORN Santobono
Napoli, , Italy
Azienda Ospedaliera di Padova
Padua, , Italy
Department of Cellular Biotechnologies and Hematology. Sapienza University
Rome, , Italy
Ospedale Casa Sollievo della Sofferenza
San Giovanni, , Italy
Hamatology Unit. Paediatric Department. University of Torino
Torino, , Italy
Sección de Hematología Pediátrica. Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Universitario Mutua de Terrassa
Barcelona, , Spain
Jefe de Servicio Oncología Y Hematología Pediátricas
Barcelona, , Spain
Servicio de Hematología Clínica, Hospital Sant Joan de Déu Barcelona
Barcelona, , Spain
Servicio de Transfusión, Hospital Universitario Niño Jesús
Madrid, , Spain
Department Haematology, Hospital Ramon y Caja
Madrid, , Spain
Hospital Universitario Virgen de la Arrixac
Murcia, , Spain
Complexo Hospitalario Universitario, Santiago
Santiago de Compostela, , Spain
Leitender Arzt, Pädiatrische Hämatologie/Onkologie Kinderspital
Lucerne, , Switzerland
St James University Hospital
Leeds, , United Kingdom
Royal Manchester Childrens Hospital,
Manchester, , United Kingdom
Children's Clinic, Royal Berkshire Hospital
Reading, , United Kingdom
Sheffield Childrens Hospital
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain more information on the study, click here/on this link.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPD422-404
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.